Assistive Technology for Mucopolysaccharidosis (MPS)
The assistive technology and equipment the NDIS funds for Mucopolysaccharidosis (MPS), how the AT process works, and how to get it into your plan.
Assistive technology (AT) — from simple aids to powered equipment — helps many people with Mucopolysaccharidosis (MPS) do things more safely and independently. This guide explains the AT that can help, how the NDIS funds it, and how to get it into your plan.
Understanding Mucopolysaccharidosis (MPS) and assistive technology
Mucopolysaccharidosis (MPS) is a group of rare, inherited metabolic conditions in which the body is missing an enzyme needed to break down complex sugar molecules called glycosaminoglycans. Without enough of the enzyme,…
AT that can help with Mucopolysaccharidosis (MPS)
The assistive technology and equipment a plan for Mucopolysaccharidosis (MPS) commonly includes are:
How the NDIS funds assistive technology
AT is funded from your Capital budget, and the process depends on cost and complexity:
Getting AT into your plan
To fund AT for Mucopolysaccharidosis (MPS), plan ahead: